These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Evolving data about subtrochanteric fractures and bisphosphonates. Shane E N Engl J Med; 2010 May; 362(19):1825-7. PubMed ID: 20335574 [No Abstract] [Full Text] [Related]
4. Bilateral femur fractures associated with short-term bisphosphonate use. Rifai A; Pourtaheri S; Carbone A; Callaghan JJ; Stadler CM; Record N; Issa K Orthopedics; 2015 Feb; 38(2):e139-42. PubMed ID: 25665120 [TBL] [Abstract][Full Text] [Related]
6. Risk of atypical femoral fracture with long-term use of alendronate (bisphosphonates) : a systemic review of literature. Agarwal S; Agarwal S; Gupta P; Agarwal PK; Agarwal G; Bansal A Acta Orthop Belg; 2010 Oct; 76(5):567-71. PubMed ID: 21138208 [TBL] [Abstract][Full Text] [Related]
7. Risk of atypical femoral fractures and osteonecrosis of the jaw associated with alendronate use compared with other oral bisphosphonates. Kharazmi M; Hallberg P; Warfvinge G; Michaëlsson K Rheumatology (Oxford); 2014 Oct; 53(10):1911-3. PubMed ID: 25099769 [No Abstract] [Full Text] [Related]
8. [Atypical femoral fractures in bisphosphonate therapy]. Ballaschk A; Kalaitzis N; Röpke M; Piatek S Unfallchirurg; 2015 Jan; 118(1):88-91. PubMed ID: 24352201 [TBL] [Abstract][Full Text] [Related]
9. More on atypical fractures of the femoral diaphysis. Kwek EB; Koh JS; Howe TS N Engl J Med; 2008 Jul; 359(3):316-7; author reply 317-8. PubMed ID: 18635442 [No Abstract] [Full Text] [Related]
10. Bisphosphonates and atypical femoral fractures: a time for reflection. Compston JE Maturitas; 2010 Jan; 65(1):3-4. PubMed ID: 19932574 [No Abstract] [Full Text] [Related]
11. Risk of femoral shaft and subtrochanteric fractures among users of bisphosphonates and raloxifene. Vestergaard P; Schwartz F; Rejnmark L; Mosekilde L Osteoporos Int; 2011 Mar; 22(3):993-1001. PubMed ID: 21165600 [TBL] [Abstract][Full Text] [Related]
12. The 5-year follow-up of a cortical stress fracture resulting in a spontaneous atypical subtrochanteric femoral fracture in a female patient with severe osteoporosis and bisphosphonate therapy over 15 years. Haschka J; Kühne F; Muschitz C; Pirker T; Kocijan R; Bittighofer C; Trubrich A; Resch H Wien Klin Wochenschr; 2011 Nov; 123(21-22):684-7. PubMed ID: 21837437 [TBL] [Abstract][Full Text] [Related]
13. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. Black DM; Kelly MP; Genant HK; Palermo L; Eastell R; Bucci-Rechtweg C; Cauley J; Leung PC; Boonen S; Santora A; de Papp A; Bauer DC; ; N Engl J Med; 2010 May; 362(19):1761-71. PubMed ID: 20335571 [TBL] [Abstract][Full Text] [Related]
14. Bisphosphonates and atypical femoral fractures. Pozzi S; Raje N N Engl J Med; 2010 Sep; 363(11):1083-4; author reply 1084-5. PubMed ID: 20848678 [No Abstract] [Full Text] [Related]
15. Bisphosphonate-related proximal femoral insufficiency fractures. Abdulla O; Beardmore S Br J Hosp Med (Lond); 2017 Dec; 78(12):726. PubMed ID: 29240500 [No Abstract] [Full Text] [Related]
17. Atypical subtrochanteric and femoral shaft fractures and possible association with bisphosphonates. Nieves JW; Cosman F Curr Osteoporos Rep; 2010 Mar; 8(1):34-9. PubMed ID: 20425089 [TBL] [Abstract][Full Text] [Related]
18. An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy? Kwek EB; Goh SK; Koh JS; Png MA; Howe TS Injury; 2008 Feb; 39(2):224-31. PubMed ID: 18222447 [TBL] [Abstract][Full Text] [Related]
19. Atypical femoral fractures: a complication of prolonged bisphosphonate therapy? Falkenberg MP Med J Aust; 2011 Jan; 194(2):102-3; author reply 103. PubMed ID: 21241227 [No Abstract] [Full Text] [Related]